Author
Listed:
- Miles A. Miller
(Center for Systems Biology, Massachusetts General Hospital (MGH), Harvard Medical School)
- Yao-Rong Zheng
(Massachusetts Institute of Technology (MIT))
- Suresh Gadde
(Laboratory of Nanomedicine and Biomaterials, Brigham and Women’s Hospital (BWH), Harvard Medical School
Present address: Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 451 Smyth Road, Ottawa, Canada K1H 8M5.)
- Christina Pfirschke
(Center for Systems Biology, Massachusetts General Hospital (MGH), Harvard Medical School)
- Harshal Zope
(Laboratory of Nanomedicine and Biomaterials, Brigham and Women’s Hospital (BWH), Harvard Medical School)
- Camilla Engblom
(Center for Systems Biology, Massachusetts General Hospital (MGH), Harvard Medical School)
- Rainer H. Kohler
(Center for Systems Biology, Massachusetts General Hospital (MGH), Harvard Medical School)
- Yoshiko Iwamoto
(Center for Systems Biology, Massachusetts General Hospital (MGH), Harvard Medical School)
- Katherine S. Yang
(Center for Systems Biology, Massachusetts General Hospital (MGH), Harvard Medical School)
- Bjorn Askevold
(Center for Systems Biology, Massachusetts General Hospital (MGH), Harvard Medical School)
- Nagesh Kolishetti
(Laboratory of Nanomedicine and Biomaterials, Brigham and Women’s Hospital (BWH), Harvard Medical School)
- Mikael Pittet
(Center for Systems Biology, Massachusetts General Hospital (MGH), Harvard Medical School)
- Stephen J. Lippard
(Massachusetts Institute of Technology (MIT))
- Omid C. Farokhzad
(Laboratory of Nanomedicine and Biomaterials, Brigham and Women’s Hospital (BWH), Harvard Medical School
King Abdulaziz University)
- Ralph Weissleder
(Center for Systems Biology, Massachusetts General Hospital (MGH), Harvard Medical School
Harvard Medical School)
Abstract
Therapeutic nanoparticles (TNPs) aim to deliver drugs more safely and effectively to cancers, yet clinical results have been unpredictable owing to limited in vivo understanding. Here we use single-cell imaging of intratumoral TNP pharmacokinetics and pharmacodynamics to better comprehend their heterogeneous behaviour. Model TNPs comprising a fluorescent platinum(IV) pro-drug and a clinically tested polymer platform (PLGA-b-PEG) promote long drug circulation and alter accumulation by directing cellular uptake toward tumour-associated macrophages (TAMs). Simultaneous imaging of TNP vehicle, its drug payload and single-cell DNA damage response reveals that TAMs serve as a local drug depot that accumulates significant vehicle from which DNA-damaging Pt payload gradually releases to neighbouring tumour cells. Correspondingly, TAM depletion reduces intratumoral TNP accumulation and efficacy. Thus, nanotherapeutics co-opt TAMs for drug delivery, which has implications for TNP design and for selecting patients into trials.
Suggested Citation
Miles A. Miller & Yao-Rong Zheng & Suresh Gadde & Christina Pfirschke & Harshal Zope & Camilla Engblom & Rainer H. Kohler & Yoshiko Iwamoto & Katherine S. Yang & Bjorn Askevold & Nagesh Kolishetti & M, 2015.
"Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug,"
Nature Communications, Nature, vol. 6(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9692
DOI: 10.1038/ncomms9692
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9692. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.